Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Candel Therapeutics Inc shares valued at $6,540 were sold by Nichols William Garrett on Jul 28 ’25. At $6.98 per share, Nichols William Garrett sold 937 shares. The insider’s holdings dropped to 52,493 shares worth approximately $0.31 million following the completion of this transaction.
Also, Nichols William Garrett sold 781 shares, netting a total of over 3,936 in proceeds. Following the sale of shares at $5.04 each, the insider now holds 52,493 shares.
Before that, WILLIAM GARRETT NICHOLS had added 3,593 shares to its account. In a trade valued at $17,606, the Officer bought Candel Therapeutics Inc shares for $4.90 each.
Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in mid February. As of February 19, 2025, Canaccord Genuity has initiated its “Buy” rating for CADL. Earlier on February 07, 2025, BofA Securities initiated its rating. Their recommendation was “a Buy” for CADL stock.
Analyzing CADL Stock Performance
On last trading session, Candel Therapeutics Inc [NASDAQ: CADL] plunged -1.52% to $5.82. The stock’s lowest price that day was $5.79, but it reached a high of $6.16 in the same session. During the last five days, there has been a surge of approximately 0.52%. Over the course of the year, Candel Therapeutics Inc shares have dropped approximately -0.68%. Shares of the company reached a 52-week high of $13.68 on 02/20/25 and a 52-week low of $4.25 on 04/09/25.
Support And Resistance Levels for Candel Therapeutics Inc (CADL)
According to the 24-hour chart, there is a support level at 5.69, which, if violated, would cause prices to drop to 5.55. In the upper region, resistance lies at 6.06. The next price resistance is at 6.29. RSI (Relative Strength Index) is 45.81 on the 14-day chart, showing neutral technical sentiment.
Is Candel Therapeutics Inc subject to short interest?
Stocks of Candel Therapeutics Inc saw a sharp rise in short interest on 2025-08-15 jumping by 0.19 million shares to 6.74 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 6.56 million shares. A jump of 2.78% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.44 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.44.
Which companies own the most shares of Candel Therapeutics Inc (CADL)?
In spite of this, 1 analysts ranked Candel Therapeutics Inc stock as Buy at the end of 2025. On December 02, 2022, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $11.
